EPISODE · Nov 7, 2025 · 4 MIN
MFN Drug Pricing Fact Sheet (Nov 6, 2025)
from The White House In Audio · host Instaread Podcast
MFN Drug Pricing Fact Sheet (Nov 6, 2025)MFN agreements: White House announces deals with Eli Lilly and Novo Nordisk to align U.S. prices with lowest peer-nation levels via TrumpRx.Big GLP‑1 price cuts:Medicare/Medicaid:Other drugs (TrumpRx pricing):Additional terms: MFN pricing guaranteed on all new medicines from Lilly/Novo; repatriation of increased foreign revenue; MFN access for every state Medicaid program.U.S. manufacturing: Novo Nordisk +$10B (incl. U.S. Wegovy tablet production if approved); Eli Lilly ≥$27B in new U.S. investments.Rationale: Addresses obesity (CDC adult prevalence ~40%) and chronic disease; argues Americans pay >3× OECD brand-name prices and shoulder ~75% of global pharma profits.Timeline of actions: EO on MFN pricing (May 12, 2025); manufacturer letters (Jul 31, 2025); five pricing deals announced since Sep 30, 2025.
What this episode covers
MFN Drug Pricing Fact Sheet (Nov 6, 2025)MFN agreements: White House announces deals with Eli Lilly and Novo Nordisk to align U.S. prices with lowest peer-nation levels via TrumpRx.Big GLP‑1 price cuts:Medicare/Medicaid:Other drugs (TrumpRx pricing):Additional terms: MFN pricing guaranteed on all new medicines from Lilly/Novo; repatriation of increased foreign revenue; MFN access for every state Medicaid program.U.S. manufacturing: Novo Nordisk +$10B (incl. U.S. Wegovy tablet production if approved); Eli Lilly ≥$27B in new U.S. investments.Rationale: Addresses obesity (CDC adult prevalence ~40%) and chronic disease; argues Americans pay >3× OECD brand-name prices and shoulder ~75% of global pharma profits.Timeline of actions: EO on MFN pricing (May 12, 2025); manufacturer letters (Jul 31, 2025); five pricing deals announced since Sep 30, 2025.
NOW PLAYING
MFN Drug Pricing Fact Sheet (Nov 6, 2025)
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m